AIMM THERAPEUTICS
AIMM Therapeutics develops antibody-based treatments by discovering the most effective antibodies against cancer and infectious diseases that are obtained from individuals who have overcome disease or from immunized animals.
AIMM THERAPEUTICS
Social Links:
Industry:
Biotechnology
Founded:
2004-01-01
Address:
Amsterdam, Noord-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.aimmtherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
31 205 66 50 56
Email Addresses:
[email protected]
Technology used in webpage:
ASP.NET IIS ASP.NET 4.0 ASP.NET Ajax IIS 7 Dutch Server Location
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
WindMIL Therapeutics
WindMIL Therapeutics translates novel insights in bone marrow immunology into life-saving cell therapies for cancer patients.
Founder
Investors List
Life Sciences Fund Amsterdam
Life Sciences Fund Amsterdam investment in Venture Round - AIMM Therapeutics
Official Site Inspections
http://www.aimmtherapeutics.com
- Host name: 89.106.200.140
- IP address: 89.106.200.140
- Location: Luxembourg
- Latitude: 49.7498
- Longitude: 6.1661
- Timezone: Europe/Luxembourg
More informations about "AIMM Therapeutics"
AIMM Therapeutics - Crunchbase Company Profile
AIMM Therapeutics is located in Amsterdam, Noord-Holland, The Netherlands. Who invested in AIMM Therapeutics? AIMM Therapeutics is funded by Life …See details»
AIMM Therapeutics - Headquarter Location, Corporate Office …
About. AIMM Therapeutics is Drug Discovery in Netherlands that focus on infectious diseases business. Founded in 2004. They cover business area such as therapeutic human …See details»
AIMM Therapeutics BV - Amsterdam Life Sciences District
Company address : Meibergdreef 59. 1105 BA Amsterdam: Company phone, e-mail & contact person +31 20 566 2145. [email protected]. Esther MerkSee details»
AIMM Therapeutics - PitchBook
AIMM Therapeutics is headquartered in Amsterdam, Netherlands. What is the size of AIMM Therapeutics? AIMM Therapeutics has 9 total employees. What industry is AIMM …See details»
AIMM Therapeutics Company Profile - Office Locations ... - Craft
AIMM Therapeutics is a company engaged in the development of therapeutic and prophylactic human monoclonal antibodies. Its current pipeline includes antibodies against the respiratory …See details»
AIMM Therapeutics - ADC Directory Member - Biopharmaceuticals
Established in 2004, AIMM Therapeutics is a biotech company comprised from a joint venture between Immpact and the Academic Medical Center at the University of Amsterdam (AMC). …See details»
AIMM Therapeutics - VentureRadar
AIMM Therapeutics is a clinical stage antibody discovery company focused on Infectious- and inflammatory-Diseases, and Oncology. ... Find out more about AIMM Therapeutics, …See details»
AIMM Therapeutics - Amsterdam, Netherlands - bionity.com
Jul 4, 2014 AIMM therapeutics B.V. was established in 2004 with the goal to develop therapeutic and prophylactic human monoclonal antibodies. AIMM's capitalizes on a breakthrough …See details»
AIMM Therapeutics - 2025 Company Profile - Tracxn
Apr 8, 2025 AIMM Therapeutics is a funded company based in Amsterdam (Netherlands), founded in 2004. It operates as a Develops therapeutic human monoclonal antibodies for …See details»
About AIMM Therapeutics - AIMM Therapeutics
AIMM Therapeutics BV is an Amsterdam based biotech company that develops human monoclonal antibodies for the treatment of cancer and infectious disease. AIMM was established ten years ago on the belief that scientists could …See details»
Aimm Therapeutics - Products, Competitors, Financials, Employees ...
Aimm Therapeutics is a clinical stage biotech company engaged in the development of antibody-based therapeutics in the biotechnology sector. The company utilizes patient-derived B cells …See details»
AIMM Therapeutics - Funding, Financials, Valuation & Investors
Jun 3, 2009 Organization. AIMM Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... AIMM Therapeutics has raised 1 round. This was a Venture - Series Unknown round raised on Jun 3, 2009. AIMM Therapeutics is funded by Life Sciences Fund Amsterdam. Funding Rounds. Edit Funding Rounds Section ...See details»
Aimm Therapeutics B.V. - BioCentury Company Profiles - BCIQ
Aimm Therapeutics B.V. - BioCentury Company Profiles for the biopharma industrySee details»
AIMM Therapeutics BV (AIMM Therapeutics BV) - 药物管线_专利_ …
Previously, he co-founded AIMM Therapeutics, Neon Therapeutics and T Cell Factory, and served as Chief Scientific Officer of Kite Pharma EU. Dr. Schumacher is an internationally …See details»
AIMM Therapeutics - VentureRadar
AIMM Therapeutics is a clinical stage antibody discovery company focused on Infectious- and inflammatory-Diseases, and Oncology. ... Find out more about AIMM Therapeutics, Antibody …See details»
What is Aimm Therapeutics? Company Culture, Mission, Values
See what employees say it's like to work at Aimm Therapeutics. Salaries, reviews, and more - all posted by employees working at Aimm Therapeutics.See details»
AIMM Therapeutics Appoints Former Head Novartis Research
Nov 8, 2012 AIMM has a broad product pipeline targeted at pathogenic viruses and bacteria, and is expanding its pipeline with drug candidates for cancer and inflammatory diseases. For …See details»
AIMM Therapeutics in Strategic Partnership with Cosmo …
Dec 19, 2012 AIMM Therapeutics (AIMM) is a leading antibody company that based on its synergistic, state-of-the-art antibody technology platform develops high affinity human …See details»
AIMM Therapeutics Presents Preclinical Data on its Four
Jun 22, 2020 AIMM Therapeutics is a privately-held biotechnology company working to isolate and develop antibodies from cured cancer survivors to create safe, effective and targeted …See details»
AIMM Therapeutics: Contact Details and Business Profile
AIMM therapeutics B.V. was established in 2004 with the goal to develop therapeutic and prophylactic human monoclonal antibodies. AIMM’s capitalizes on a breakthrough proprietary technology to isolate human monoclonal antibodies for prevention and treatment of infectious diseases, inflammatory diseases and cancer.See details»